Certain information indicated with [***] in this document has been omitted from this exhibit because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential. GENERIC API SUPPLY AGREEMENTGeneric Api Supply Agreement • March 29th, 2023 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations • Delaware
This GENERIC API SUPPLY AGREEMENT (“Agreement”) is made this 2nd day of January 2020 (“Effective Date”) by and between Euticals Inc. (“Supplier”), with a place of business at 2460 W. Bennett Street, Springfield, MO 65807 and Avadel CNS Pharmaceuticals, LLC (“Customer”), with a place of business at 16640 Chesterfield Grove Road, Suite 200, Chesterfield, MO 63005. Supplier and Customer may be referred to herein as a “Party” or “Parties” as the context requires.
Certain information indicated with [***] in this document has been omitted from this exhibit because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential. MANUFACTURING AGREEMENT BETWEEN FLAMEL IRELAND...Manufacturing Agreement • March 29th, 2023 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations
THIS MANUFACTURING AGREEMENT (this “Agreement”) dated as of 1 October 2022 (“Effective Date”) is hereby made by and between Flamel Ireland Limited, a company duly organized and existing under the laws of Ireland, having its registered office at 10 Earlsfort Terrace, Dublin 2, D02T380 IRELAND (“AVADEL”) and Recipharm Pessac, a French Société par Actions Simplifiée with the registered number 807 679 386 and having its principal place of business at 11 avenue Gustave Eiffel, 33600 Pessac, FRANCE (“RPC”).
